Navigation Links
Cost of Psoriasis Drugs Rising Faster Than Others
Date:1/18/2010

Increases outpace consumer products as well as other meds, study finds,,

MONDAY, Jan. 18 (HealthDay News) -- The cost of treating psoriasis is rising faster than inflation, says a U.S. study, which also found that newer, biologically-derived treatments cost more than traditional systemic therapies.

The researchers created a cost model to analyze the total cost of systemic therapy for psoriasis, a chronic autoimmune skin disease that affects 4.5 million to 7.5 million Americans and costs the nation's health-care industry more than $3 billion a year.

The cost for each type of systemic therapy (such as oral medications) was calculated by using the average wholesale price of each drug plus the cost of office visits, laboratory tests and monitoring.

"Current total and annual costs for systemic psoriasis therapies ranged from $1,197 (methotraxate [a traditional systemic therapy]) to $27,577 (alefacept [a biologic], two 12-week courses)," wrote Dr. Vivianne Beyer of St. Vincent Hospital in Indianapolis and Dr. Stephen E. Wolverton of the Indiana University School of Medicine.

Costs for phototherapy (exposure to ultraviolet light) ranged from $3,083 to $7,288, and costs for biologics ranged from $18,384 to $27,577.

"Trends in the average wholesale price of brand-name psoriasis therapies from 2000 through 2008 demonstrate an average increase of 66 percent," they wrote. "Thus, costs of several brand-name psoriasis drugs greatly outpaced the rate of inflation for all items and all prescription drugs."

During this time, the urban Consumer Price Index for all items increased 25.8 percent and 30.1 percent for all prescription drugs.

The study is in the January issue of the Archives of Dermatology.

"Although the tendency of psoriasis drug costs to outpace the Consumer Price Index-Urban rate is shared by both traditional and biologic therapies, traditional therapies remain much more affordable than biologic therapies," the researchers wrote. "When considering the expense of biologic therapies, even relatively small increases in price become significant, such as the 14-percent increase during an eight-year period seen with infliximib."

More information

The American Academy of Family Physicians has more about psoriasis.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Jan. 18, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Newer Drug More Effective in Psoriasis Treatment
2. Placebo Effect Helps Some Psoriasis Patients
3. Millions Mark World Psoriasis Day on Oct. 29
4. Largest Survey of Its Kind Finds the Psychological and Social Effects of Psoriasis Greater for Women
5. First-Ever NJ Psoriasis Walk Coming to Paramus on Sept. 12
6. Tim Gunn Hosts Addressing Psoriasis(TM) Fashion Show to Raise Awareness of Psoriasis
7. Gene variation is major genetic determinant of psoriasis
8. Psoriasis Video Contest Launched to Encourage Psoriasis Patients to Connect and Collaborate
9. Largest Survey of Its Kind Finds That People With Psoriasis Are at Risk for Other Medical Conditions
10. Winners of the Addressing Psoriasis(TM) Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn
11. Psoriasis Cure Now Welcomes Institute of Medicine Report Urging Comparative Effectiveness Research on Psoriasis, But Worries About Risk of Rationing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: